Keith McCrae, MD, Cleveland Clinic (IMAGE)

Cleveland Clinic

Keith McCrae, MD, Cleveland Clinic

Caption

A clinical trial led by Dr. Keith McCrae of Cleveland Clinic has demonstrated that the cancer drug pomalidomide is safe and effective in treating hereditary hemorrhagic telangiectasia (HHT).

Credit

Cleveland Clinic

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.